Budi Starch Sweetener Tbk vs Charlie Hospital Semarang Tbk. — how do they compare? Budi Starch Sweetener Tbk trades at Rp206 (market cap 935.79B, 20.1K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Budi Starch Sweetener Tbk is the larger of the two by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 20.1K). Which is the better fit depends on your goals.
| BUDI | RSCH | |
|---|---|---|
Market Cap | 935.79B | 715.5B |
Volume | 20.1K | 30.64M |
Lot | 201 | 306.41K |
Turnover | 4.18M | 7.98B |
Average Price | 207.72 | 260.34 |
Value | 4.18M | 7.98B |
Indicative Equilibrium Price | 208 | 256 |
Indicative Equilibrium Volume | 13.8K | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Read more on BUDI →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →